Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

shutterstock_124071745_resized for site2016 Full Year Financial Results

Genmab published its 2016 Full Year financial results and held an investor conference call on February 22. Click here to listen to the archived webcast. Click here to view the report. Click here to view the presentation. Click here to view the 2016 summary in Danish. Click here to download the podcast. 

InvestorPortal

To register your email address for electronic shareholder communications or to update your settings, log on to the InvestorPortal


 

5 Dec 150x110ASH 2016 Data Review Meeting

Genmab hosted an ASH 2016 Data Review Meeting on December 5 in San Diego, CA.The meeting included the presentation of daratumumab data presented at the 2016 American Society of Hematology Annual Meeting (December 3-6).The event was also be webcast and an archive of the webcast is available here.  To download the slides of the presentation, click hereThis meeting was NOT an official program of the ASH Annual Meeting.